Bausch Health Companies Inc. Gain (Loss) on Investments
Bausch Health Companies Inc. (BHC) reported Gain (Loss) on Investments of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-01.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2017-03-01
- Bausch Health Companies Inc. gain (loss) on investments for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- Bausch Health Companies Inc. gain (loss) on investments for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- Bausch Health Companies Inc. gain (loss) on investments for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- Bausch Health Companies Inc. gain (loss) on investments for the quarter ending 2014-12-31 was $287.10M.
- Bausch Health Companies Inc. gain (loss) on investments for fiscal 2016 was $0.00.
- Bausch Health Companies Inc. gain (loss) on investments for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- Bausch Health Companies Inc. gain (loss) on investments for fiscal 2014 was $293.00M, a 4951.72% increase from fiscal 2013.
- Bausch Health Companies Inc. gain (loss) on investments for fiscal 2013 was $5.80M, a 176.19% increase from fiscal 2012.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 3 month as first filed | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 6 month as first filed | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 9 month as first filed | Gain (Loss) on Investments 12 month | Gain (Loss) on Investments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-01 | |||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 derived: sum of 2 quarters · filed 2017-03-01 | $0.00 derived: sum of 3 quarters · filed 2017-03-01 | $0.00 10-K · filed 2017-03-01 | ||||
| 2015-09-30 | $0.00 10-Q · filed 2015-10-26 | $0.00 derived: sum of 2 quarters · filed 2015-10-26 | $0.00 10-Q · filed 2015-10-26 | |||||
| 2015-06-30 | $0.00 10-Q · filed 2015-07-28 | $0.00 10-Q · filed 2015-07-28 | ||||||
| 2014-12-31 | $287.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $290.50M derived: sum of 2 quarters · filed 2017-03-01 | $293.00M derived: sum of 3 quarters · filed 2017-03-01 | $293.00M 10-K · filed 2017-03-01 | $292.60M 10-K · filed 2015-02-25 | |||
| 2014-09-30 | $3.40M 10-Q · filed 2015-10-26 | $5.90M derived: sum of 2 quarters · filed 2015-10-26 | $5.90M 10-Q · filed 2015-10-26 | $5.90M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | $2.50M 10-Q · filed 2015-07-28 | $2.50M 10-Q · filed 2015-07-28 | $2.50M derived: sum of 3 quarters · filed 2016-04-29 | $2.50M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-09 | $0.00 derived: sum of 2 quarters · filed 2016-04-29 | $0.00 derived: sum of 3 quarters · filed 2016-04-29 | $3.90M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | $0.00 derived: sum of 2 quarters · filed 2016-04-29 | $3.90M derived: sum of 3 quarters · filed 2016-04-29 | $5.80M 10-K · filed 2016-04-29 | $5.82M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $0.00 10-Q · filed 2014-10-24 | $3.90M derived: sum of 2 quarters · filed 2014-10-24 | $5.80M 10-Q · filed 2014-10-24 | $5.82M 10-Q · filed 2013-11-01 | $5.88M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2013-06-30 | $3.90M 10-Q · filed 2014-08-01 | $3.96M 10-Q · filed 2013-08-07 | $5.80M 10-Q · filed 2014-08-01 | $5.82M 10-Q · filed 2013-08-07 | $5.88M derived: sum of 3 quarters · filed 2015-02-25 | $5.88M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | $1.90M 10-Q · filed 2014-05-09 | $1.86M 10-Q · filed 2013-05-03 | $1.98M derived: sum of 2 quarters · filed 2015-02-25 | $1.98M derived: sum of 3 quarters · filed 2015-02-25 | $1.94M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $76.00K derived: sum of 2 quarters · filed 2015-02-25 | $41.00K derived: sum of 3 quarters · filed 2015-02-25 | $2.10M 10-K · filed 2015-02-25 | $2.06M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-01 | -$35.00K derived: sum of 2 quarters · filed 2013-11-01 | $2.02M 10-Q · filed 2013-11-01 | $2.01M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | -$35.00K 10-Q · filed 2013-08-07 | $2.02M 10-Q · filed 2013-08-07 | $2.01M derived: sum of 3 quarters · filed 2014-02-28 | $1.87M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $2.06M 10-Q · filed 2013-05-03 | $2.05M derived: sum of 2 quarters · filed 2014-02-28 | $1.91M derived: sum of 3 quarters · filed 2014-02-28 | $23.07M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -$151.00K derived: sum of 2 quarters · filed 2014-02-28 | $21.01M derived: sum of 3 quarters · filed 2014-02-28 | $22.78M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | -$140.00K 10-Q · filed 2012-11-05 | $21.02M derived: sum of 2 quarters · filed 2012-11-05 | $22.79M 10-Q · filed 2012-11-05 | $22.79M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $21.16M 10-Q · filed 2012-08-03 | $22.93M 10-Q · filed 2012-08-03 | $22.93M derived: sum of 3 quarters · filed 2013-02-28 | $17.92M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $1.77M 10-Q · filed 2012-05-04 | $1.77M derived: sum of 2 quarters · filed 2013-02-28 | -$3.24M derived: sum of 3 quarters · filed 2013-02-28 | -$3.63M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$5.00M derived: sum of 2 quarters · filed 2013-02-28 | -$5.40M derived: sum of 3 quarters · filed 2013-02-28 | -$5.55M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | -$5.00M 10-Q · filed 2011-11-04 | -$5.40M derived: sum of 2 quarters · filed 2011-11-04 | -$5.55M 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | -$392.00K 10-Q · filed 2011-08-08 | -$547.00K 10-Q · filed 2011-08-08 | ||||||
| 2010-03-31 | -$155.00K 10-Q · filed 2011-05-10 | |||||||
| 2009-12-31 | $17.59M 10-K · filed 2012-02-29 | |||||||
| 2008-12-31 | -$4.53M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |